nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabrafenib—LIMK1—RAC1 signaling pathway—WASF1—conduct disorder	0.0784	0.0784	CbGpPWpGaD
Dabrafenib—LIMK1—Regulation of actin dynamics for phagocytic cup formation—WASF1—conduct disorder	0.0751	0.0751	CbGpPWpGaD
Dabrafenib—RAF1—FSH signaling pathway—CGA—conduct disorder	0.0589	0.0589	CbGpPWpGaD
Dabrafenib—LIMK1—Fcgamma receptor (FCGR) dependent phagocytosis—WASF1—conduct disorder	0.0567	0.0567	CbGpPWpGaD
Dabrafenib—BRAF—TSH signaling pathway—CGA—conduct disorder	0.0417	0.0417	CbGpPWpGaD
Dabrafenib—SIK1—Circadian rythm related genes—SLC6A4—conduct disorder	0.0362	0.0362	CbGpPWpGaD
Dabrafenib—LIMK1—Regulation of Actin Cytoskeleton—WASF1—conduct disorder	0.0348	0.0348	CbGpPWpGaD
Dabrafenib—SIK1—Circadian rythm related genes—DRD4—conduct disorder	0.0341	0.0341	CbGpPWpGaD
Dabrafenib—RAF1—TSH signaling pathway—CGA—conduct disorder	0.0288	0.0288	CbGpPWpGaD
Dabrafenib—RAF1—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2A—conduct disorder	0.0274	0.0274	CbGpPWpGaD
Dabrafenib—BRAF—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.0214	0.0214	CbGpPWpGaD
Dabrafenib—LIMK1—Innate Immune System—MB21D1—conduct disorder	0.0191	0.0191	CbGpPWpGaD
Dabrafenib—BRAF—Regulation of Actin Cytoskeleton—WASF1—conduct disorder	0.0174	0.0174	CbGpPWpGaD
Dabrafenib—SIK1—TGF-beta Signaling Pathway—EP300—conduct disorder	0.0165	0.0165	CbGpPWpGaD
Dabrafenib—BRAF—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0161	0.0161	CbGpPWpGaD
Dabrafenib—RAF1—VEGFA-VEGFR2 Pathway—WASF1—conduct disorder	0.0157	0.0157	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by VEGF—WASF1—conduct disorder	0.0148	0.0148	CbGpPWpGaD
Dabrafenib—RAF1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.0148	0.0148	CbGpPWpGaD
Dabrafenib—LIMK1—Innate Immune System—POLR3A—conduct disorder	0.014	0.014	CbGpPWpGaD
Dabrafenib—RAF1—Ion channel transport—GABRA2—conduct disorder	0.0132	0.0132	CbGpPWpGaD
Dabrafenib—BRAF—Neuronal System—GABRA2—conduct disorder	0.0123	0.0123	CbGpPWpGaD
Dabrafenib—RAF1—Regulation of Actin Cytoskeleton—WASF1—conduct disorder	0.012	0.012	CbGpPWpGaD
Dabrafenib—LIMK1—Innate Immune System—WASF1—conduct disorder	0.0118	0.0118	CbGpPWpGaD
Dabrafenib—SIK1—Circadian rythm related genes—EP300—conduct disorder	0.0118	0.0118	CbGpPWpGaD
Dabrafenib—RAF1—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0111	0.0111	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—MB21D1—conduct disorder	0.0111	0.0111	CbGpPWpGaD
Dabrafenib—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.0107	0.0107	CbGpPWpGaD
Dabrafenib—RAF1—Neuronal System—GABRA2—conduct disorder	0.00853	0.00853	CbGpPWpGaD
Dabrafenib—ABCG2—HIF-2-alpha transcription factor network—EP300—conduct disorder	0.00827	0.00827	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—POLR3A—conduct disorder	0.00816	0.00816	CbGpPWpGaD
Dabrafenib—BRAF—Transmission across Chemical Synapses—COMT—conduct disorder	0.00775	0.00775	CbGpPWpGaD
Dabrafenib—BRAF—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00769	0.00769	CbGpPWpGaD
Dabrafenib—RAF1—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00745	0.00745	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00721	0.00721	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—WASF1—conduct disorder	0.00687	0.00687	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways in Glioblastoma—EP300—conduct disorder	0.00678	0.00678	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—MB21D1—conduct disorder	0.0066	0.0066	CbGpPWpGaD
Dabrafenib—SLCO1B3—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00643	0.00643	CbGpPWpGaD
Dabrafenib—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00612	0.00612	CbGpPWpGaD
Dabrafenib—RAF1—Kit receptor signaling pathway—EP300—conduct disorder	0.0061	0.0061	CbGpPWpGaD
Dabrafenib—BRAF—Neuronal System—COMT—conduct disorder	0.00594	0.00594	CbGpPWpGaD
Dabrafenib—BRAF—Neuronal System—MAOA—conduct disorder	0.00589	0.00589	CbGpPWpGaD
Dabrafenib—SLC22A8—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00569	0.00569	CbGpPWpGaD
Dabrafenib—RAF1—Regulation of retinoblastoma protein—EP300—conduct disorder	0.00558	0.00558	CbGpPWpGaD
Dabrafenib—RAF1—Transmission across Chemical Synapses—COMT—conduct disorder	0.00536	0.00536	CbGpPWpGaD
Dabrafenib—RAF1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00532	0.00532	CbGpPWpGaD
Dabrafenib—ABCG2—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.00487	0.00487	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00485	0.00485	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—POLR3A—conduct disorder	0.00484	0.00484	CbGpPWpGaD
Dabrafenib—SLC22A6—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00475	0.00475	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways in Glioblastoma—EP300—conduct disorder	0.00469	0.00469	CbGpPWpGaD
Dabrafenib—RAF1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00459	0.00459	CbGpPWpGaD
Dabrafenib—SLCO1B1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00432	0.00432	CbGpPWpGaD
Dabrafenib—BRAF—Integrated Breast Cancer Pathway—EP300—conduct disorder	0.00416	0.00416	CbGpPWpGaD
Dabrafenib—RAF1—Neuronal System—COMT—conduct disorder	0.00411	0.00411	CbGpPWpGaD
Dabrafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00409	0.00409	CbGpPWpGaD
Dabrafenib—RAF1—Neuronal System—MAOA—conduct disorder	0.00408	0.00408	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—WASF1—conduct disorder	0.00408	0.00408	CbGpPWpGaD
Dabrafenib—ABCG2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.004	0.004	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—MB21D1—conduct disorder	0.00384	0.00384	CbGpPWpGaD
Dabrafenib—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00328	0.00328	CbGpPWpGaD
Dabrafenib—CYP2C8—Biological oxidations—COMT—conduct disorder	0.00327	0.00327	CbGpPWpGaD
Dabrafenib—CYP2C8—Biological oxidations—MAOA—conduct disorder	0.00325	0.00325	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—CGA—conduct disorder	0.00324	0.00324	CbGpPWpGaD
Dabrafenib—CYP2C8—Metapathway biotransformation—COMT—conduct disorder	0.00323	0.00323	CbGpPWpGaD
Dabrafenib—LIMK1—Developmental Biology—EP300—conduct disorder	0.00322	0.00322	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—CGA—conduct disorder	0.00321	0.00321	CbGpPWpGaD
Dabrafenib—RAF1—TGF-beta Signaling Pathway—EP300—conduct disorder	0.00321	0.00321	CbGpPWpGaD
Dabrafenib—LIMK1—Innate Immune System—EP300—conduct disorder	0.00285	0.00285	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—POLR3A—conduct disorder	0.00282	0.00282	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00278	0.00278	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CGA—conduct disorder	0.00277	0.00277	CbGpPWpGaD
Dabrafenib—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.00263	0.00263	CbGpPWpGaD
Dabrafenib—RAF1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.00238	0.00238	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—WASF1—conduct disorder	0.00237	0.00237	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—WASF1—conduct disorder	0.00222	0.00222	CbGpPWpGaD
Dabrafenib—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00216	0.00216	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—CGA—conduct disorder	0.00216	0.00216	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—CGA—conduct disorder	0.002	0.002	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CGA—conduct disorder	0.00192	0.00192	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—DRD4—conduct disorder	0.00182	0.00182	CbGpPWpGaD
Dabrafenib—CYP3A4—Biological oxidations—COMT—conduct disorder	0.00176	0.00176	CbGpPWpGaD
Dabrafenib—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.00174	0.00174	CbGpPWpGaD
Dabrafenib—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.00173	0.00173	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—EP300—conduct disorder	0.00166	0.00166	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—DRD4—conduct disorder	0.00155	0.00155	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—WASF1—conduct disorder	0.00154	0.00154	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—COMT—conduct disorder	0.00145	0.00145	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—MAOA—conduct disorder	0.00144	0.00144	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.0014	0.0014	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—CGA—conduct disorder	0.00124	0.00124	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—HTR2A—conduct disorder	0.00118	0.00118	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.00112	0.00112	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—EP300—conduct disorder	0.00112	0.00112	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—EP300—conduct disorder	0.00109	0.00109	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—CGA—conduct disorder	0.00108	0.00108	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—DRD4—conduct disorder	0.00107	0.00107	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—HTR2A—conduct disorder	0.00101	0.00101	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—EP300—conduct disorder	0.000985	0.000985	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—COMT—conduct disorder	0.000974	0.000974	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—MAOA—conduct disorder	0.000967	0.000967	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000938	0.000938	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—COMT—conduct disorder	0.000902	0.000902	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—MAOA—conduct disorder	0.000896	0.000896	CbGpPWpGaD
Dabrafenib—BRAF—Disease—EP300—conduct disorder	0.000765	0.000765	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—HTR2A—conduct disorder	0.0007	0.0007	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—CGA—conduct disorder	0.000666	0.000666	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—EP300—conduct disorder	0.000622	0.000622	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—EP300—conduct disorder	0.000574	0.000574	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—COMT—conduct disorder	0.00056	0.00056	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—MAOA—conduct disorder	0.000556	0.000556	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000539	0.000539	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—EP300—conduct disorder	0.000536	0.000536	CbGpPWpGaD
Dabrafenib—RAF1—Disease—EP300—conduct disorder	0.00053	0.00053	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—COMT—conduct disorder	0.000488	0.000488	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—MAOA—conduct disorder	0.000484	0.000484	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—EP300—conduct disorder	0.000418	0.000418	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—EP300—conduct disorder	0.000387	0.000387	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—EP300—conduct disorder	0.000371	0.000371	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—COMT—conduct disorder	0.0003	0.0003	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—MAOA—conduct disorder	0.000298	0.000298	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—EP300—conduct disorder	0.00024	0.00024	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—EP300—conduct disorder	0.000209	0.000209	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—EP300—conduct disorder	0.000129	0.000129	CbGpPWpGaD
